CBO & COO of Crispr Therapeutics Ag (30-Year Financial, Insider Trades) Lawrence Otto Klein (insider trades) sold 100,000 shares of CRSP on 03/23/2021 at an average price of $128.05 a share. The total sale was $12.8 million.
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. Crispr Therapeutics Ag has a market cap of $8.64 billion; its shares were traded at around $114.600000 with and P/S ratio of 10418.19.
Directors and Officers Recent Trades:
- CBO & COO Lawrence Otto Klein sold 100,000 shares of CRSP stock on 03/23/2021 at the average price of $128.05. The price of the stock has decreased by 10.5% since.
- Director Bradley J Phd Bolzon sold 30,374 shares of CRSP stock on 03/22/2021 at the average price of $132.37. The price of the stock has decreased by 13.42% since.
For the complete insider trading history of CRSP, click here
.This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
